Influence of Frailty on Cardiovascular Events and Mortality in Patients With COPD.
Recruiting
Observational Study
Role of Frailty in COPD
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Azienda Ospedaliero-Universitaria di Modena · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Observational study on the influence of frailty on cardiovascular risk in COPD.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with age ≥18 years, with diagnosis of COPD of at least 1 year, in stable condition, without acute exacerbation in the last 30 days and/or all-cause hospitalisation in the last 3 months
* Smoking history of ≥ 10 pack/years
* Diagnosis of COPD according to GOLD guidelin…
Contacts